The Rac inhibitor HV-107 as a potential therapeutic for metastatic breast cancer

BACKGROUND: The significant challenge in treating triple-negative breast cancer (TNBC) lies in its high rate of distant metastasis. To address this, inhibiting metastasis formation in TNBC is vital. Rac is a key player in cancer metastasis. Previously, we developed Ehop-016, a Rac inhibitor that suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Crespo, Grace Velez, Ortiz, Jescelica, O’Farrill, Eliud Hernández, Vlaar, Cornelis P., Inyushin, Mikhail, Kucheryavykh, Yuriy, Kucheryavykh, Lilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268403/
https://www.ncbi.nlm.nih.gov/pubmed/37316799
http://dx.doi.org/10.1186/s10020-023-00678-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268403/
https://www.ncbi.nlm.nih.gov/pubmed/37316799
http://dx.doi.org/10.1186/s10020-023-00678-7

Ejemplares similares